Gallant is developing FDA-regulated, off-the-shelf mesenchymal stromal cell therapies to rapidly modulate inflammation, support tissue repair, and make stem cell treatment broadly available to cats and dogs.
What today’s science really says about safety, regulation, and clinical use of stem cell therapies.